Trusopt Ukonserveret 20 mg/ml øjendråber, opløsning, enkeltdosisbeholder Dinamarca - danés - Lægemiddelstyrelsen (Danish Medicines Agency)

trusopt ukonserveret 20 mg/ml øjendråber, opløsning, enkeltdosisbeholder

paranova danmark a/s - dorzolamidhydrochlorid - øjendråber, opløsning, enkeltdosisbeholder - 20 mg/ml

1:1 DROPS 12,5+12,5 mg/ml oral opløsning Dinamarca - danés - Lægemiddelstyrelsen (Danish Medicines Agency)

1:1 drops 12,5+12,5 mg/ml oral opløsning

canntrust inc - cannabidiol (cbd), dronabinol (thc), ekstrakt af cannabisblomst - oral opløsning - 12,5+12,5 mg/ml

CBD DROPS <2+25 mg/ml oral opløsning Dinamarca - danés - Lægemiddelstyrelsen (Danish Medicines Agency)

cbd drops <2+25 mg/ml oral opløsning

canntrust inc - cannabidiol (cbd), dronabinol (thc), ekstrakt af cannabisblomst - oral opløsning - <2+25 mg/ml

THC DROPS 25+<2 mg/ml oral opløsning Dinamarca - danés - Lægemiddelstyrelsen (Danish Medicines Agency)

thc drops 25+<2 mg/ml oral opløsning

canntrust inc - cannabidiol (cbd), dronabinol (thc), ekstrakt af cannabisblomst - oral opløsning - 25+<2 mg/ml

Jcovden (previously COVID-19 Vaccine Janssen) Unión Europea - danés - EMA (European Medicines Agency)

jcovden (previously covid-19 vaccine janssen)

janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - vacciner - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older. brug af denne vaccine bør være i overensstemmelse med de officielle anbefalinger.

Vaxzevria (previously COVID-19 Vaccine AstraZeneca) Unión Europea - danés - EMA (European Medicines Agency)

vaxzevria (previously covid-19 vaccine astrazeneca)

astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - vacciner - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. brug af denne vaccine bør være i overensstemmelse med de officielle anbefalinger.

Deltyba Unión Europea - danés - EMA (European Medicines Agency)

deltyba

otsuka novel products gmbh - delamanid - tuberkulose, multidrugt-resistent - antimyco-bakterielle midler - deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (mdr-tb) in adults, adolescents, children and infants with a body weight of at least 10 kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see sections 4. 2, 4. 4 og 5. det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler..

Vanflyta Unión Europea - danés - EMA (European Medicines Agency)

vanflyta

daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukæmi, myeloid - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.

Mirtazapin "Stada" 15 mg smeltetabletter Dinamarca - danés - Lægemiddelstyrelsen (Danish Medicines Agency)

mirtazapin "stada" 15 mg smeltetabletter

stada arzneimittel ag - mirtazapin - smeltetabletter - 15 mg

Mirtazapin "Stada" 30 mg smeltetabletter Dinamarca - danés - Lægemiddelstyrelsen (Danish Medicines Agency)

mirtazapin "stada" 30 mg smeltetabletter

stada arzneimittel ag - mirtazapin - smeltetabletter - 30 mg